LOM
PRTK

Loeb Offshore Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Loeb Offshore Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-8,417
Closed -$321K – 248
2013
Q3 		$321K Buy
+8,417
New +$301K 0.1% 159

Other funds holding PRTK

RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Loeb Offshore Management's PRTK Position: Q4 2013 in Review

Loeb Offshore Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2013, closing a stake of 8,417 shares — an estimated $321K sold.

Loeb Offshore Management first reported a position in PRTK in Q3 2013 and held it in 1 quarter. The position peaked at $321K in Q3 2013. 39 funds tracked by Wall St. Rank hold PRTK as of Q4 2013.

  • Loeb Offshore Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Loeb Offshore Management sold 8,417 Paratek Pharmaceuticals, Inc. shares in Q4 2013, an estimated $321K.
  • Loeb Offshore Management first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2013 and held it in 1 quarter.
  • Loeb Offshore Management's Paratek Pharmaceuticals, Inc. position peaked at $321K in Q3 2013.
  • 39 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2013.

Based on Loeb Offshore Management's 13F filing for Q4 2013, filed 14 Feb 2014.